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ABSTRACT
The current goal of treatment in irritable bowel syndrome 
(IBS) focuses primarily on symptom management and attempts 
to improve quality of life. Several treatments are at the disposal 
of physicians; lifestyle and dietary management, pharmacological 
treatments and psychological interventions are the most used and 
recommended. Psychological treatments have been proposed as 
viable alternatives or compliments to existing care models. Most 
forms of psychological therapies studied have been shown to be 
helpful in reducing symptoms and in improving the psychological 
component of anxiety/depression and health-related quality of 
life. According to current NICE/NHS guidelines, physicians should 
consider referral for psychological treatment in patients who do 
not respond to pharmacotherapy for a period of 12 months and 
develop a continuing symptom profile (described as refractory irritable 
bowel syndrome). Cognitive behavioral therapy (CBT) is the best 
studied treatment and seems to be the most promising therapeutic 
approach. However, some studies have challenged the effectiveness 
of this therapy for irritable bowel syndrome. One study concluded 
that cognitive behavioral therapy is no more effective than attention 
placebo control condition and another study showed that the 
beneficial effects wane after six months of follow-up. A review of 
mind/body approaches to irritable bowel syndrome has therefore 
suggested that alternate strategies targeting mechanisms other than 
thought content change might be helpful, specifically mindfulness and 
acceptance-based approaches. In this article we review these new 
psychological treatment approaches in an attempt to raise awareness 
of alternative treatments to gastroenterologists that treat this clinical 
syndrome.
Key words: Irritable bowel syndrome. Mental disorders. 
Psychotherapy. Cognitive therapy. Mindfulness. Acceptance and 
commitment therapy.
INTRODUCTION
A recent systematic review and meta-analysis has 
demonstrated a global prevalence of IBS of 11%, a per-
centage that varies considerably in some instances accord-
ing to the geographic region and diagnostic criteria used to 
define the syndrome (1). On the other hand, the percentage 
of patients seeking health care related to IBS reaches 12% 
in Primary Care practices and is by far the largest subgroup 
seen in gastroenterology clinics (2).
IBS has been defined according to the new Rome IV 
criteria (3) as recurrent abdominal pain associated with 
two or more of the following conditions: related to defe-
cation, associated with a change in the frequency of stool 
and associated with a change in the consistency of stool. 
Symptom onset should occur at least six months before the 
diagnosis and symptoms should be present on average at 
least one day a week in the last three months.
The etiology and pathophysiology of IBS is unknown. 
Several pathogenic factors responsible for IBS have been 
proposed, such as genetic and environmental factors (4), 
abnormal gut motility (5), visceral hypersensitivity (6), 
post-infectious inflammatory mechanisms (7), psycholog-
ical morbidity, physical, emotional and sexual abuse (8), 
bacterial overgrowth (9) and changes in intestinal micro-
biota (10), among others. However, none of them seem to 
clearly explain the mechanisms that trigger the syndrome.
Nowadays, a model taking into account the numerous 
physiological symptoms (e.g., altered motility, gut hyper-
sensitivity) but also psychosocial factors and interactions 
between the brain and gut seems to be shifting the under-
standing of IBS (11).
This biopsychosocial interpretation of IBS (11), heavily 
influenced by discoveries in the fields of psychosomatics 
and psychoneuroimmunology (12,13), is now recognized 
as one of the most complete and best fitting models for 
this illness. 
In the model we can see how changes in early life/pre-
morbid genetic and environmental (parenting, infection) 
factors might play a role in the development of both psy-
chosocial (susceptibility to stress, psychological illness, 
psychological traits) and physiological (abnormal motility, 
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visceral hypersensitivity) factors leading to the expression 
of IBS symptoms and coping behaviors. Also, the interplay 
between psychosocial and physiological factors via the 
interactions between the central nervous system (CNS) and 
the enteric nervous system (ENS) is thought to influence 
IBS expression (11). These biopsychosocial interactions 
are therefore thought to have an impact on patient quality 
of life and their approach to health care.
Historically, the absence of a structural or organic 
explanation for IBS and anecdotal observations of patient 
behavior has always seemed to support the possible pres-
ence of psychological morbidity. 
Early research concluded that the etiology of IBS was 
linked to hypochondriasis or psychogenic traits (14), with 
some authors even considering IBS to be part of a psy-
chiatric illness (15). This is not surprising as most studies 
show that between 54% and 94% of IBS patients meet cri-
teria for at least one (axis I) psychiatric disorder (16). IBS 
patients usually have associated mental disorders with the 
most frequent being anxiety (69%) followed by affective 
disorders (38%) (17); other common symptoms include 
nervousness, rumination, panic attacks, posttraumatic 
stress, social phobia, somatization and eating disorders. 
Less common symptoms include sleep disorders, loss of 
appetite and exhaustion (18-20).
This is particularly relevant given the current guidelines 
for interventions in IBS. The current goal of treatment in IBS 
focuses primarily on symptom management and attempts to 
improve quality of life (21). Therefore, after a positive diag-
nosis several treatments are at the disposal of physicians, 
with lifestyle and dietary management, pharmacological 
treatments and psychological interventions as the most used 
and recommended (21,22). The practice guidelines for the 
management of IBS-constipation (23) is a useful resource 
that has been recently published in this journal. 
Figure 1 shows an adapted flow chart of care result-
ing from a consensus between the recommendations of 
the British Society of Gastroenterology (22), the National 
Institute for Health and Clinical Excellence (NICE) (24) 
and the American College of Gastroenterology (25). 
Although lifestyle and dietary management (e.g., exer-
cise, fiber intake) have limited efficacy in IBS, generally 
speaking their safety and general health net benefits seem 
to justify their inclusion as a first line of management (22). 
With regard to conventional medical treatment (i.e., phar-
macological), several studies and reviews have highlight-
ed the limited efficacy of these approaches in providing 
adequate relief for IBS patients. Nevertheless, some drugs 
that are being used recently, such as linaclotide, rifaximine, 
melatonine or antidepressants, are showing good results 
(26). Therefore, other approaches such as psychological 
treatments have been proposed as viable alternatives or 
compliments to existing models of care (27). 
Most forms of psychological therapies studied have 
been shown to be helpful in reducing symptoms and in 
improving psychological components of anxiety/depres-
sion and health-related quality of life (22,27,28). The suc-
cess of psychological therapies for IBS global outcomes 
means that it is being implemented as a standard adjunctive 
treatment in the United Kingdom. According to current 
NICE/NHS (24) guidelines, physicians should consider 
referral for psychological treatment in patients who do not 
respond to pharmacotherapy for a period of 12 months and 
develop a continuing symptom profile (described as refrac-
tory IBS). Therefore, those patients who do not improve 
with first line treatments can benefit from psychological 
interventions, which may reduce pain and other symptoms 
and also improve quality of life.
The most studied and used forms of psychological treat-
ment for IBS are relaxation training, brief psychodynamic 
psychotherapy, CBT, hypnotherapy and several forms of 
self-help. These forms of treatment have been used both in 
individual and group settings and are thought to be accept-
able for patients, especially those who identify psycholog-
ical factors as triggers for their IBS (29). Table 1 provides 
a simple overview of the most important psychological 
therapies in terms of understanding the (psycho)pathol-
ogy, objectives of therapy, the techniques used and their 
strengths/weaknesses in an attempt to facilitate their com-
prehension beyond the psychological field. 
Fig. 1. Flowchart of care in IBS.
Address patients 
concerns. Use explanation 
and reassurance
Pharmacological 
treatments
Lifestyle and dietary 
management
Psychological treatments
Establishing a positive 
diagnosis
650 B. SEBASTIÁN SÁNCHEZ ET AL. Rev esp enfeRm Dig
Rev esp enfeRm Dig 2017;109(9):648-657
Ta
b
le
 1
. C
o
m
p
ar
is
o
n
 b
et
w
ee
n
 t
h
e 
m
ai
n
 p
sy
ch
o
lo
g
ic
al
 t
h
er
ap
ie
s 
in
 t
er
m
s 
o
f 
u
n
d
er
st
an
d
in
g
 t
h
e 
(p
sy
ch
o
)p
at
h
o
lo
g
y,
 o
b
je
ct
iv
es
 in
 t
h
er
ap
y,
  
te
ch
n
iq
u
es
 u
se
d
 a
n
d
 s
tr
en
g
th
s/
w
ea
kn
es
se
s 
U
nd
er
st
an
di
ng
 o
f 
(p
sy
ch
o)
pa
th
ol
og
y
O
bj
ec
tiv
es
 in
 t
he
ra
py
H
ow
? 
(T
ec
hn
iq
ue
s)
St
re
ng
th
s 
an
d 
w
ea
kn
es
se
s
Ps
yc
ho
dy
na
m
ic
 
ps
yc
ho
th
er
ap
y
– 
 M
en
ta
l p
he
no
m
en
a 
ar
is
e 
fr
om
 
co
nfl
ic
tin
g 
fo
rc
es
 →
 s
ym
pt
om
s 
as
 
an
 a
tt
em
pt
 t
o 
re
st
or
e 
ba
la
nc
e
– 
 Fi
xa
tio
ns
/r
eg
re
ss
io
ns
 in
 d
iff
er
en
t 
st
ag
es
 o
f 
ps
yc
ho
-s
ex
ua
l 
de
ve
lo
pm
en
t
– 
 M
ak
e 
co
ns
ci
ou
s 
th
e 
un
co
ns
ci
ou
s 
(a
ch
ie
ve
d 
by
 o
ve
rc
om
in
g 
re
si
st
an
ce
 t
o 
th
e 
m
em
or
y 
of
 
su
pp
re
ss
ed
/r
ep
re
ss
ed
 e
ve
nt
s)
– 
 Fr
ee
 a
ss
oc
ia
tio
n,
 in
te
rp
re
ta
tio
n 
of
 
dr
ea
m
s,
 h
yp
no
si
s,
 e
tc
.
(-
) U
nv
er
ifi
ab
le
 a
ss
er
tio
ns
, t
he
or
ie
s 
no
t 
sc
ie
nt
ifi
ca
lly
 p
ro
ve
n
(-
) E
xt
en
si
ve
 t
he
ra
py
 
C
og
ni
tiv
e 
be
ha
vi
or
al
 
th
er
ap
y 
(C
BT
)
– 
 Ps
yc
ho
lo
gi
ca
l d
is
or
de
rs
 a
re
 d
ue
 t
o 
a 
di
st
or
te
d 
au
to
m
at
ic
 p
ro
ce
ss
in
g 
of
 r
ea
lit
y 
(d
is
or
de
rs
 d
iff
er
 in
 t
he
 
irr
at
io
na
l c
og
ni
tiv
e 
co
nt
en
t)
– 
 Re
lie
f 
of
 s
ym
pt
om
at
ol
og
y 
(r
ed
uc
tio
n/
el
im
in
at
io
n 
of
 
sy
m
pt
om
s)
– 
 To
 c
ha
ng
e 
fe
el
in
gs
 o
r 
be
ha
vi
or
, 
th
ou
gh
ts
 a
nd
 b
el
ie
fs
 m
us
t 
be
 
ch
an
ge
d
– 
 C
og
ni
tiv
e 
te
ch
ni
qu
es
 a
im
ed
 a
t 
ch
an
gi
ng
 t
ho
ug
ht
s 
an
d 
be
lie
fs
 
(e
.g
., 
qu
es
tio
ni
ng
 o
f 
ev
id
en
ce
, 
di
re
ct
 d
is
ag
re
em
en
t,
 t
ho
ug
ht
 
st
op
pi
ng
, e
tc
.)
– 
 Be
ha
vi
or
al
 t
ec
hn
iq
ue
s 
(e
.g
., 
in
 
vi
vo
 e
xp
os
ur
e,
 r
el
ax
at
io
n 
tr
ai
ni
ng
, 
et
c.
)
 (-
) L
ac
k 
of
 a
 u
ni
fy
in
g 
th
eo
re
tic
al
 
fr
am
ew
or
k
(+
) G
re
at
 e
xp
an
si
on
, a
 lo
t 
of
 
ev
id
en
ce
(-
) U
nk
no
w
n 
m
ec
ha
ni
sm
 o
f 
ac
tio
n:
 
ef
fe
ct
iv
en
es
s 
du
e 
to
 t
he
 b
eh
av
io
ra
l 
co
m
po
ne
nt
(-
) E
ff
ec
ts
 a
re
 n
ot
 m
ai
nt
ai
ne
d 
in
 t
he
 
lo
ng
 t
er
m
C
on
te
xt
ua
l t
he
ra
pi
es
 
(A
C
T,
 m
in
df
ul
ne
ss
)
– 
 Ps
yc
ho
lo
gi
ca
l i
nfl
ex
ib
ili
ty
 
(i.
e.
, t
he
 p
er
so
n 
ac
ts
 in
 a
 
w
ay
 t
ha
t 
pr
ov
id
es
 s
om
e 
re
lie
f 
of
 t
he
 s
ym
pt
om
s,
 b
ut
 is
 
co
un
te
rp
ro
du
ct
iv
e 
in
 t
he
 lo
ng
 
te
rm
) i
s 
a 
co
re
 p
ro
ce
ss
 u
nd
er
ly
in
g 
m
os
t 
of
 t
he
 p
sy
ch
ol
og
ic
al
 
di
so
rd
er
s 
 
– 
 A
lte
rin
g 
th
e 
pa
tt
er
n 
of
 
ps
yc
ho
lo
gi
ca
l i
nfl
ex
ib
ili
ty
 b
y 
ch
an
gi
ng
 t
he
 f
un
ct
io
n 
of
 
sy
m
pt
om
s 
(c
ha
ng
in
g 
th
e 
w
ay
 t
he
 
pe
rs
on
 r
ea
ct
s 
to
 t
ho
ug
ht
s 
an
d 
fe
el
in
gs
) r
at
he
r 
th
an
 f
oc
us
in
g 
on
 c
ha
ng
in
g 
an
d 
el
im
in
at
in
g 
sy
m
pt
om
s
– 
 Tr
ai
ni
ng
 a
 b
eh
av
io
ra
l r
ep
er
to
ire
 o
f 
ps
yc
ho
lo
gi
ca
l fl
ex
ib
ili
ty
 t
ow
ar
ds
 
th
e 
pe
rs
on
s 
va
lu
ed
 d
ire
ct
io
ns
– 
 Fu
nc
tio
na
l a
na
ly
si
s 
of
 b
eh
av
io
r 
by
 t
he
 p
at
ie
nt
 a
nd
 c
re
at
io
n 
of
 h
op
el
es
sn
es
s 
(a
na
ly
si
s 
of
 
th
ou
gh
ts
 a
nd
 e
m
ot
io
ns
, r
ea
ct
io
ns
 
to
 t
he
m
 a
nd
 t
he
 s
ho
rt
 a
nd
 lo
ng
 
te
rm
 e
ff
ec
ts
 d
er
iv
ed
 f
ro
m
 t
he
se
 
re
ac
tio
ns
)
– 
 C
la
rifi
ca
tio
n 
of
 v
al
ue
s
– 
 M
in
df
ul
ne
ss
 a
nd
 d
ef
us
io
n 
te
ch
ni
qu
es
 (m
et
ap
ho
rs
 a
nd
 
ex
pe
rie
nt
ia
l e
xe
rc
is
es
)
(+
) W
el
l d
efi
ne
d 
th
eo
ry
 (r
el
at
io
na
l 
fr
am
e 
th
eo
ry
) a
nd
 p
hi
lo
so
ph
y 
(f
un
ct
io
na
l c
on
te
xt
ua
lis
m
)
(+
) T
he
ra
py
 c
lo
se
ly
 li
nk
ed
 t
o 
re
se
ar
ch
(+
) E
ff
ec
ts
 a
re
 m
ai
nt
ai
ne
d 
in
 t
he
 
lo
ng
 t
er
m
(+
) A
pp
lic
ab
le
 t
o 
m
an
y 
di
ff
er
en
t 
ps
yc
ho
lo
gi
ca
l d
is
or
de
rs
 a
nd
 m
ed
ic
al
 
co
nd
iti
on
s
2017, Vol. 109, N.º 9 NEW PSYCHOLOGICAL THERAPIES FOR IRRITABLE BOWEL SYNDROME: MINDFULNESS, ACCEPTANCE 651 
 AND COMMITMENT THERAPY (ACT)
Rev esp enfeRm Dig 2017;109(9):648-657
So far, CBT is the best studied and has been proposed 
as the most promising treatment (26,30). However, some 
studies have challenged the effectiveness of CBT for IBS. 
In particular, one study concluded that CBT is no more 
effective than a attention placebo control condition (31) 
and another demonstrated that the effects seem to wane 
after six months of follow-up (32). In addition, studies 
exploring active components of CBT found that cogni-
tive change (one of the key components of CBT) was not 
associated with any significant changes in outcome (33). 
A review of mind/body approaches to IBS has therefore 
suggested that strategies that target mechanisms other 
than thought content change might be helpful, specifically 
mindfulness and acceptance-based approaches (29).
In this article, we will review these new psychological 
treatment approaches in an attempt to raise awareness of 
these alternative treatments to gastroenterologists that treat 
this clinical syndrome. 
Bibliographic search strategy
The biomedical literature search was performed in the 
PubMed database of the United States National Library of 
Medicine (pubmed.gov). The MeSH (Medical Subjects Head-
ings) terms used to conduct the review and search of scien-
tific evidence were: Irritable Bowel Syndrome [in the title] 
combined with Mindfulness [in the title] and also with Accep-
tance and Commitment Therapy or Acceptance-Commitment, 
respectively using the Boolean operator AND/OR. The results 
obtained were filtered with the following limits: types of stud-
ies: Systematic Reviews, Meta-Analysis, Guideline, Practice 
Guideline, Consensus Development Conference (and Consen-
sus Development Conference NIH), Randomized Controlled 
Trial, Controlled Clinical Trial and Clinical Trial; age: adults 
(19 or more years); language: English and/or Spanish; also the 
abstract was available for all articles. 
The database was searched for relevant studies pub-
lished up until July 2016.
Initially, the title, abstract and keywords were screened 
of every record identified with the search strategy. All 
potentially relevant articles were retained and the full text 
of these studies obtained and evaluated in detail. Irrelevant 
articles were excluded on the basis of the title or abstract. 
Foreign language papers were translated when necessary.
One author (BS) performed the data extraction, which 
was then assessed by another author (NBF). The differenc-
es between reviewers were resolved by discussion until a 
consensus was reached.
THE PSYCHOLOGY OF IBS
The psychosocial profile of the IBS patient
Although physical symptoms are at the forefront of IBS 
patient presentation, several studies have shown that a key 
factor in the maintenance and aggravation of IBS relates to 
psychosocial factors (cognitive and emotional) (34). Most 
patients are likely to report experiences such as worrying 
about their symptoms, consequences and duration, anxiety, 
depression, stress, shame and anger (35,36). Within these psy-
chosocial phenomena, the most commonly reported is gas-
trointestinal specific anxiety (GSA). This is defined as “the 
cognitive, affective and behavioral response stemming from 
fear of gastrointestinal sensations, symptoms and the context 
in which these visceral sensations and symptoms occur” (37). 
GSA is thought to contribute to IBS maintenance by acting 
as an endogenous stressor that perpetuates alterations in auto-
nomic and neuroendocrine responses even in the absence of 
an external stressor (38). The literature has shown that higher 
levels of GSA are related to higher symptom severity and 
lower quality of life in IBS (37,39,40). 
Linked to GSA is the behavior displayed by IBS 
patients, with avoidance being the main strategy used to 
cope with the aversive experiences of the illness, even in 
the absence of symptoms (41). Patients tend to avoid sit-
uations or events such as certain foods or food-related sit-
uations (e.g., eating out), social or work related situations 
(e.g., gatherings or meetings), leisure or travelling, per-
sonal relationships and intimate contact (42). Even though 
most patients believe that this type of response is essential 
for the management of their condition, they also recognize 
this to be the main cause of their suffering (43). 
The literature seems to support this with several studies 
showing that avoidant coping mechanisms are associat-
ed with poorer quality of life, high levels of anxiety and 
depression (44,45). Furthermore, it has been shown that 
recurrent avoidance as a coping strategy is only effective 
in the short term and has a rebound effect in the long term 
(for example, the more one tries to eliminate a thought, the 
more frequent it becomes) (46-48). 
Strategies such as distraction are not useful and can 
increase pain awareness (49). Therefore, it has been sug-
gested that the content or nature of the distressing expe-
riences (physical or psychological) does not cause the 
suffering in IBS, but rather how patients relate to these 
experiences and try to deal with them.
The alternative seems to be discriminating, observ-
ing and accepting private experiences without trying to 
alter their form but altering the function of the behavior 
(50,51). From this perspective, the goal of psychological 
intervention is to help the patient develop and enhance 
skills that allow him/her to view and accept the private 
events related to his/her illness (thoughts and feelings of 
shame or guilt, fear, anxiety, stress, specific symptoms, 
etc.) without changing them and therefore directing and 
maintaining behavior toward his/her values and life goals. 
Contextual behavioral models and IBS
As previously noted, some authors (29) have recom-
mended that psychological treatments of IBS should not 
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focus on changing the form and frequency of the symp-
toms or experiences related to IBS, but to change how 
patients deal with these experiences instead. 
Treatment models developed from a contextual behav-
ioral (or third wave) perspective seem to address this issue. 
New psychological treatments have arisen as a result of 
significant shifts in the philosophy of science (from mech-
anism to functional contextualism) (52) and advances in 
the study of language and cognition as forms of behavior 
(relational frame theory) (53). 
As a whole, these treatment models aim to: a) build 
broad, flexible and effective behavioral repertoires in 
the patient that are in line with their personal values; b) 
modifying the way the patient relates to their experiences 
(symptoms, thoughts, emotions and sensations), so instead 
of focusing on eliminating them (53,54) the patient can 
effect valued behavior in their presence; and c) instil 
moment-by-moment awareness so that the patient can 
sense the context and function of their experiences whilst 
not becoming entangled in them to the point that they dic-
tate their behavior. 
Third-wave approaches include a wide number of ther-
apeutic models such as dialectical behavior therapy (DBT) 
(55), mindfulness-based cognitive therapy (MBCT) (56), 
behavioral activation (BA) (57), as well as functional ana-
lytic psychotherapy (FAP) (58). 
For the purposes of this article, we will be using ACT as 
a frame of reference as it provides the most comprehensive 
account of how these interventions can be useful for IBS 
whilst also having the most robust evidence base (59). 
ACT brings a new conceptualization of the suffering of 
patients with IBS in the following way: “A proportion of 
IBS patients can be functionally characterized by the use of 
behaviors that seek to control, eliminate or alter the phys-
ical, emotional and cognitive experiences associated with 
IBS both in the presence or absence of symptoms. These 
behaviors seem to be motivated by an excessive fusion with 
a self-conceptualization of being an IBS patient, fusion 
with unhelpful illness specific beliefs or cognitions and by 
a dominance of feared future consequences or comparison 
with an idealized past. IBS patients also tend to choose to 
engage in these avoidant behaviors that provide short-term 
relief from their experiences over engaging in behaviors 
that are values-consistent and that might lead to better life 
satisfaction on the long-term.” (60).
These are simultaneously occurring processes that con-
tribute to this process known as psychological inflexibility 
(PI), narrowing the patient’s repertoire and taking them to 
inaction, persistent avoidance and to an increasing limita-
tion of life (61).
Acceptance and commitment therapy (pronounced as 
one word, “ACT”) (62) is a new behavioral therapeutic 
approach that uses processes of acceptance, defusion (see 
below), commitment and behavior change to increase psy-
chological flexibility, defined as “the ability to contact the 
present moment more fully as a conscious human being 
and to either change or persist in behaviors when doing so 
serves valued ends” (63). 
The use of defusion in ACT could be behaviorally 
described as a way to train discrimination between private 
events and the individual self, i.e., the individual is able to 
observe events such as thoughts, emotions, memories or 
physical sensations as part of a repertoire of experiences 
that a human being is likely to experience, without becom-
ing entangled in these experiences to a point that it exerts 
undue influence on their behavior (64). In order to contact 
this type of discrimination on a moment-by-moment basis, 
ACT attempts to reinforce a sense of being in the present in 
patients via mindfulness practices. In this defused stance, the 
patient is then more likely (or accepting) to hold distressing 
experiences if it then allows him/her to move and behave 
coherently towards a valued end (e.g., family, friendships).
Some mindfulness practices are described and used in 
more depth in other third-wave therapies such as the mind-
fulness-based stress reduction (MBSR) program (65), one 
of the first procedures to integrate Eastern practices such as 
meditation and yoga into the management of chronic pain 
and illness. Similarly, MBCT includes formal meditation 
and promotes a decentered view of thoughts, emotions and 
body sensations (66). 
The importance of looking at the function of MBSR 
and MBCT procedures should be noted. Although these 
techniques are aimed to train the person to become more 
aware of the symptoms and not behave according to them 
(that is, to change the function of the symptoms), they can 
be easily interpreted or used as a way to reduce or change 
the symptoms (and thus behave accordingly to them). 
This model has received a lot of support and has proved 
to be very effective in health conditions (59) such as dia-
betes (67), epilepsy (68), tinnitus (69) and chronic pain 
(70-72), and its application to IBS is under consideration 
(73,74).
EVIDENCE OF THE APPLICATION OF THIRD 
GENERATION THERAPIES TO IBS
Some encouraging results have been found with regard 
to the application of third-wave psychological therapies 
in IBS. 
The following is a narrative review of studies on the 
application of mindfulness techniques with CBT compo-
nents, the application of mindfulness techniques alone and 
finally, the application of ACT.
Mindfulness combined with CBT
One study (75) applied a CBT-based protocol combin-
ing mindfulness techniques and exposure aimed at reduc-
ing GSA. The inclusion criteria were female gender and 
age between 18 and 65 years. Patients were excluded if 
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any somatic or psychiatric disorder deemed to interfere 
with the treatment was present. A mindfulness component 
allows patients to be less likely to act on impulses, which, 
together with the exposure component (provocation of 
symptoms, prevention of response and exposure to situa-
tions that evoke symptoms), helps the patient to accept his/
her symptoms and aversive thoughts. This protocol led to a 
significant improvement in all symptoms (except for diar-
rhea) and quality of life. The same effects were observed 
in an internet-based version of the same protocol and were 
maintained for up to six months (76,77).
Mindfulness alone
The first non-controlled trial (78) was conducted in a 
veteran population with the following exclusion criteria: 
a) psychotic disorder; b) mania or bipolar disorder; c) 
personality disorders; d) suicidal or homicidal ideation; 
and e) active substance abuse or dependence. The results 
showed that participation in an MBSR group was asso-
ciated with improvements in IBS-related quality of life 
and GSA. Changes in mindfulness skills were correlated 
with improvements in GSA in those meeting the Rome 
IBS criteria, and there was a significant decrease in the 
percentage of subjects meeting Rome IBS criteria during 
the 6-month follow-up. 
A randomized controlled clinical trial of the appli-
cation of mindfulness to IBS (79) was conducted in a 
female only population who had a medical diagnosis of 
IBS and who also met the Rome II criteria for IBS. Exclu-
sion criteria included: a) diagnosis of mental illness with 
psychotic features; b) a history of an inpatient admission 
for a psychiatric disorder within the past two years; c) 
a history or current symptoms of inflammatory bowel 
disease or gastrointestinal malignancy; d) active liver or 
pancreatic disease; e) uncontrolled lactose intolerance; f) 
celiac disease; g) a history of abdominal trauma or sur-
gery involving gastrointestinal resection; or h) pregnancy 
or intention to become pregnant during the study. This 
protocol involved an 8-week mindfulness training that 
included techniques such as body scan, meditation, yoga 
and exercises that help the patient to learn to observe 
thoughts and body sensations in a non-judgmental man-
ner. This protocol had a clinically significant therapeu-
tic effect on the severity of bowel symptoms (26.4% 
reduction compared to 6.2% in the control group), and 
improved the quality of life related to health, even at 
three months of follow-up. In addition, the protocol also 
had an effect on psychological symptoms (anxiety, gen-
eral severity, visceral anxiety) that was thought to have 
been mediated by an increase in mindfulness (79). The 
authors suggest that the program allows the patient to 
learn specific techniques with lasting effects which can 
be performed in groups and are more cost-effective than 
other treatments such as CBT or hypnosis.
A second controlled study (80) was conducted with the 
following exclusion criteria: a) diagnosis of a DSM-IV axis 
I mood, anxiety, or psychotic disorder; b) current use of anti-
psychotics; or c) previous participation in an MBSR group. In 
order to ensure the stability of medication during the course of 
the study, if there had been a change in medication, patients 
were asked to wait three months before being enrolled in the 
next cohort for randomization and not to change regimens or 
dosages for the duration of the study. Results showed a great-
er improvement of symptoms (from moderate to severe) in 
patients in a MBSR group in comparison to a control group. 
However, a rebound effect of symptoms during follow-up was 
observed, i.e., the rate of improvement due to the program 
was not found to be maintained over time. In addition, the 
control group also improved over time, perhaps due to the 
beneficial effects of attention, self-monitoring and the antici-
pation of participating in the MBSR group, and no differences 
were observed between the groups in terms of quality of life, 
alterations of mood and spirituality.
Finally, a recent study (81) comparing mindful-
ness-based treatments (MBT) with CBT has shown that 
the former is more effective in reducing IBS symptoms 
and has a longer lasting effect.
ACT
The application of ACT in IBS is still in an early stage, 
although significant steps have recently been made for 
its implementation. For example, a pilot study (82) that 
analyzed the effectiveness of ACT in adolescents with 
functional abdominal pain (some with IBS) showed that 
12 to 14 sessions were effective in improving quality of 
life, levels of depression, anxiety and somatic complaints 
during the first month of follow-up. Methodological short-
comings limit the conclusions of the study, although this 
preliminary evidence suggests that ACT could be an effec-
tive approach to IBS.
The first study (74) to investigate the application of ACT 
in IBS was conducted with the following specific exclusion 
criteria: a) pregnant or breastfeeding women; b) any symp-
toms suggestive of significant inflammatory or neoplastic 
gastrointestinal disorder (such as unexplained weight loss 
or unexplained rectal bleeding); and c) a known cognitive 
impairment. The protocol included a one-day group work-
shop combined with working with a self-help workbook 
for a period of two months (83). The limitations of this 
study were a highly selected population, a very specific 
format of intervention, and the absence of a formal control 
group condition (this was compensated by using a within 
subject design). However, the results showed that ACT 
was effective at reducing symptoms, GSA and the use of 
IBS-related avoidance behaviors, and improved IBS-re-
lated and general quality of life. These results were main-
tained at the 6-month follow-up with a trend for further 
gains (albeit non-statistically significant). 
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Part of this study also involved the development of a 
measure of psychological flexibility specific to IBS, the 
Irritable Bowel Syndrome Acceptance and Action Ques-
tionnaire (IBSAAQ) (84). The development of this scale 
allowed the authors to explore the role of psychological 
flexibility in the biopsychosocial model of IBS. The results 
indicated that psychological flexibility was a significant 
predictor of all IBS-related outcomes beyond the effects 
of symptom severity or cognitive variables. In addition, 
the authors also explored the putative mechanism through 
which an ACT intervention works, i.e., that improvement 
in outcomes occurs via an increase in psychological flex-
ibility. The authors reported that all gains in IBS related 
outcomes following the ACT intervention were fully medi-
ated by increases in psychological flexibility thus favoring 
the validity of the intervention model.
FINAL CONSIDERATIONS
The research conducted to date on the implementation 
of third-generation therapies for IBS has shown promis-
ing results. Two recent reviews have shown that (85,86) 
MBT, when combined with CBT, appears to be effective in 
reducing symptoms and improving quality of life in IBS. 
Furthermore, improvement in symptoms seems to occur 
even when accounting for the different IBS presentation 
types (e.g., constipation or predominant diarrhea). Howev-
er, both reviews indicated that the results should be inter-
preted with caution as most of the studies were of poor 
quality and had many methodological limitations (small 
and heterogeneous samples, dropouts, risk of bias, etc.).
On the other hand, the ACT approach, which incor-
porates a more comprehensive model that is based on a 
growth agenda (getting patients to enact their valued behav-
iors) rather than trying to address a deficit agenda (changing 
symptoms or thoughts), seems to be more effective. 
Indeed, those patients who have trouble managing their 
bowel disorder and meet criteria for psychological comor-
bidity might be the most suitable candidates for this kind 
of psychological therapy. Especially when the condition 
interferes with daily life and progressively results in a 
restricted life. For example, if a patient avoids different 
situations (e.g., personal relationships and intimate contact, 
work related situations, leisure or travelling) this might be 
a good indication. Nevertheless, a patient’s functional anal-
ysis of behavior might be an effective general recommen-
dation in order to explore if a pattern of PI is occurring. 
Over time, a pattern of PI may alter a person’s behavior 
resulting in more severe symptoms (both physical and psy-
chological) and a lower quality of life. The core therapeutic 
strategy of ACT could aid in changing the PI pattern and 
the patient can start to build a more flexible and effective 
way of living with the illness.
Although ACT could be conceived primarily as a form 
of individual therapy, it is extremely flexible and can be 
adapted to a group format and can also be used in a tele-
phone (87) or Internet (75) format. This allows the adjust-
ment to economic resources and available time within 
hospitals, medical specialty centers and health centers. 
In addition, training in this therapeutic approach is not 
as intensive as in other intervention procedures (CBT, for 
example) and can be rolled out to different professionals 
(not just psychologists) (88). 
Empirical evidence of ACT for IBS, albeit preliminary, 
shows that the results are maintained in the long-term (up 
to six-months of follow-up) and that improvements occur 
through the hypothesized path of an increase in psycho-
logical flexibility. These results are very encouraging and 
invite different professionals to continue working in this 
direction. 
These findings add to the extensive literature that has 
shown the usefulness of ACT in improving different med-
ical conditions, by either promoting healthy behavior (dia-
betes control, smoking cessation and weight maintenance) 
or by changing the attitude that patients have with their 
difficult experiences of the illness (chronic pain), resulting 
in significant improvements in quality of life (74).
Interesting pioneering work with patients with chronic 
pain (64) have shown the benefits of the joint work of dif-
ferent professionals (physiotherapists, occupational ther-
apists, nurses, doctors and psychologists) in the patient’s 
experience of the illness and the related quality of life. 
Similarly, patients with other illnesses such as IBS (and 
other functional gastrointestinal disorders) may benefit 
from the interaction between gastroenterologists, nutri-
tionists/dieticians, nurses and psychologists. Even though 
the purpose of pharmacological treatment is to affect the 
pathophysiological mechanism or the symptoms, initially 
it is not incompatible with psychological therapy, and IBS 
patients could actually benefit from the combination of 
both approaches. However, the idea is that all professionals 
work together in unison to teach patients how to behave 
effectively when faced with symptoms, feelings of shame 
or anxiety, and, instead of trying to control them, learn to 
integrate them as part of their life. Thus, from a contextual 
perspective, and with the supporting empirical evidence, 
the goal will be to focus on training the person to observe 
and react to symptoms (stress, for example) in a way that 
is consistent to his/her objectives, goals and values. After 
all, although IBS patients have an illness, they also have 
a life worth living, even if they have to carry the burden 
of the illness.
In summary, although ACT was originally designed for 
psychological disorders, it has recently been applied to 
medical conditions with very promising results. The pres-
ent review is the first compilation of the new evidence 
from a psychological perspective for non-psychologists (in 
this case, for gastroenterologists). Despite the limitations 
of the initial attempts (few studies with few and highly 
selected populations and other methodological short-
comings), this new direction is very promising and more 
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research is needed so that we can address this syndrome 
in a more precise and efficient way. ACT is not difficult 
to apply (brief protocols can be used and better results 
are obtained if different professionals work together as a 
team), nor to evaluate (there are general measures of PI 
as well as specific measures for IBS). Thus, we hope this 
review sheds light on this treatment option and that more 
practitioners start to implement these therapies in order to 
help patients with IBS to live their life in a better way and 
accept their illness as a part of it. 
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